Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
The original version of this Article omitted from the Author Contributions statement that ‘R.S. and J.G.R contributed equally to this work.’ This has been corrected in both the PDF and HTML versions of the Article.
Main Authors: | Jennifer L. Caswell-Jin, Katherine McNamara, Johannes G. Reiter, Ruping Sun, Zheng Hu, Zhicheng Ma, Jie Ding, Carlos J. Suarez, Susanne Tilk, Akshara Raghavendra, Victoria Forte, Suet-Feung Chin, Helen Bardwell, Elena Provenzano, Carlos Caldas, Julie Lang, Robert West, Debu Tripathy, Michael F. Press, Christina Curtis |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-10456-x |
Similar Items
-
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
by: Jennifer L. Caswell-Jin, et al.
Published: (2019-02-01) -
Calling sample mix-ups in cancer population studies.
by: Andy G Lynch, et al.
Published: (2012-01-01) -
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome
by: Deborah R. Caswell, et al.
Published: (2017-07-01) -
Impact of Intervention Measures on MRSA Clonal Type and Carriage Site Prevalence
by: Marco Cassone, et al.
Published: (2016-05-01) -
Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen
by: Neil L. Berinstein, et al.
Published: (2018-05-01)